| |
|
|
|
AzurRx BioPharma Inc.  
|
|
1.045 -0.025 (-0.02%) |
08-21 16:00 |
|
Open: |
1.08 |
Pre close: |
1.07 |
Target:
|
1.31 
|
|
High: |
1.15 |
Low: |
1.02 |
Resistance:
|
1.12
1.28
|
|
Volume: |
536,479 |
Market Cap: |
26M |
Support:
|
0.86
0.72
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.02
 |
MACD |
MACD(12,26):
|
-0.07 |
|
MA(20): |
1.01 |
Signal(12,26,9): |
-0.10 |
|
MA(100): |
1.84 |
Stochastic Oscillator |
%K(14,3):
|
77.29 |
|
MA(250): |
2.05 |
%D(3): |
70.16 |
|
Average Volume(K) |
3-Month: |
21031
|
52-Week |
High:
|
3.75 |
|
10-Days: |
14141 |
Low: |
0.86 |
|
RSI |
RSI(14):
|
44.87 |
Change(%): |
-58.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.869 |
Return on Equity (ttm) |
-764.0 |
Shares Out. (M) |
12.60 |
|
EPS Est. Current Year |
-0.850 |
Return on Assets (ttm) |
-125.2 |
Shares Float (M) |
16.23 |
|
EPS Est. Next Year |
-0.670 |
PEG Ratio |
0.00 |
% Held by Insiders |
32.82 |
|
EPS Est. Next Quarter |
-0.160 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
14.89 |
|
Forward EPS |
-0.640 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
266 |
|
Book Value (p.s.) |
0.150 |
EBITDA (p.s.) |
-1.067 |
P/E |
-1.20 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
6.97 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-11.28 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-4.89 |
P/CF |
-1.17 |
|
|
|
|
|
|
